Anti-GHI™ monoclonal antibody
Pre-made anti-GHI™ monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to GHI™/GHI™ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0904-Ab-1/ GM-Tg-hg-IP0904-Ab-2 | Anti-Human GHI™ monoclonal antibody | Human |
| GM-Tg-rg-IP0904-Ab-1/ GM-Tg-rg-IP0904-Ab-2 | Anti-Rat GHI™ monoclonal antibody | Rat |
| GM-Tg-mg-IP0904-Ab-1/ GM-Tg-mg-IP0904-Ab-2 | Anti-Mouse GHI™ monoclonal antibody | Mouse |
| GM-Tg-cynog-IP0904-Ab-1/ GM-Tg-cynog-IP0904-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GHI™ monoclonal antibody | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0904-Ab-1/ GM-Tg-felg-IP0904-Ab-2 | Anti-Feline GHI™ monoclonal antibody | Feline |
| GM-Tg-cang-IP0904-Ab-1/ GM-Tg-cang-IP0904-Ab-2 | Anti-Canine GHI™ monoclonal antibody | Canine |
| GM-Tg-bovg-IP0904-Ab-1/ GM-Tg-bovg-IP0904-Ab-2 | Anti-Bovine GHI™ monoclonal antibody | Bovine |
| GM-Tg-equg-IP0904-Ab-1/ GM-Tg-equg-IP0904-Ab-2 | Anti-Equine GHI™ monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. | GM-Tg-hg-IP0904-Ab-1/ GM-Tg-hg-IP0904-Ab-2; GM-Tg-rg-IP0904-Ab-1/ GM-Tg-rg-IP0904-Ab-2; GM-Tg-mg-IP0904-Ab-1/ GM-Tg-mg-IP0904-Ab-2; GM-Tg-cynog-IP0904-Ab-1/ GM-Tg-cynog-IP0904-Ab-2; GM-Tg-felg-IP0904-Ab-1/ GM-Tg-felg-IP0904-Ab-2; GM-Tg-cang-IP0904-Ab-1/ GM-Tg-cang-IP0904-Ab-2; GM-Tg-bovg-IP0904-Ab-1/ GM-Tg-bovg-IP0904-Ab-2; GM-Tg-equg-IP0904-Ab-1/ GM-Tg-equg-IP0904-Ab-2 |
| Products Name | Anti-GHI™ monoclonal antibody |
| Format | mab |
| Target Name | GHI™ |
| Protein Sub-location | Introcelluar Protein |
| Category of antibody | |
| Derivation (species) | Mouse |
| CH1+2+3 Isotype (Receptor identification) | IgG |
| Type of Light Chain (VD-LC) | N/A |
| Expression platform | Mammalian Expression |
| Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
| Tag | Fc |
| Products description | Pre-made anti-GHI™ monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
| Target Antigen | GM-Tg-g-IP0904-Ag-1 | Recombinant multi-species GHI™/ DERP2/ HSPC282 protein |
Target information
| Target ID | GM-IP0904 |
| Target Name | GHI™ |
| Gene ID | 27069,66092,290596,702691,479266,101082521,404143,100052687 |
| Gene Symbol and Synonyms | 1010001P14Rik,DERP2,GHI™,HSPC282,MICS1,My021,PTD010,™BIM5 |
| Uniprot Accession | Q9H3K2,Q5XIA8 |
| Uniprot Entry Name | GHI™_HUMAN,GHI™_RAT |
| Protein Sub-location | Introcelluar Protein |
| Category | |
| Disease | N/A |
| Gene Ensembl | ENSG00000165678 |
| Target Classification | N/A |
The target: GHI™, gene name: GHI™, also named as DERP2, HSPC282, MICS1, My021, PTD010, ™BIM5. Involved in inner mitochondrial membrane organization and negative regulation of release of cytochrome c from mitochondria. Located in mitochondrion. Is integral component of mitochondrial inner membrane. [provided by Alliance of Genome Resources, Apr 2022].
About Gmab


GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.

